Cholesterol-lowering therapy for smokers

被引：0
|
作者：
Jackson, PR [1 ]
机构：
[1] Univ Sheffield, Royal Hallamshire Hosp, Sect Clin Pharmacol & Therapeut, Sheffield S10 2JF, S Yorkshire, England
来源：
LANCET | 2001年 / 357卷 / 9260期
关键词：
D O I：
10.1016/S0140-6736(05)71661-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：960 / 960
页数：1
相关论文
共 50 条
  • [41] CHOLESTEROL-LOWERING AND CORONARY VASOMOTION
    JIALAL, I
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (05): : 324 - 324
  • [42] Probiotics Cholesterol-lowering Probiotic
    不详
    [J]. MEDIZINISCHE WELT, 2017, 68 (06): : 274 - 274
  • [43] CHOLESTEROL-LOWERING EFFECT OF PECTIN
    JUDD, PA
    KAY, RM
    TRUSWELL, AS
    [J]. NUTRITION AND METABOLISM, 1976, 20 (03): : 181 - 181
  • [44] Nutraceuticals and cholesterol-lowering action
    Cicero, Arrigo F. G.
    Parini, Angelo
    Rosticci, Martina
    [J]. IJC METABOLIC & ENDOCRINE, 2015, 6 : 1 - 4
  • [45] COMPARISON OF CHOLESTEROL-LOWERING REGIMENS
    SNYDER, S
    [J]. AMERICAN FAMILY PHYSICIAN, 1990, 42 (03) : 761 - 768
  • [46] Risks of cholesterol-lowering therapies
    Hibbeln, JR
    Salem, N
    [J]. BIOLOGICAL PSYCHIATRY, 1996, 40 (07) : 686 - 687
  • [47] ADHERENCE TO CHOLESTEROL-LOWERING DIETS
    GRUNDY, SM
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (06) : 1139 - 1139
  • [48] CHOLESTEROL-LOWERING AGENTS AND CHOLELITHIASIS
    LOFLAND, HB
    CLARKSON, TB
    [J]. ARTERY, 1975, 1 (03) : 226 - 227
  • [49] CHOICE OF CHOLESTEROL-LOWERING DRUGS
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1988, 30 (774): : 85 - 88
  • [50] Risk factors for stroke and the effect of cholesterol-lowering therapy with pravastatin
    West, M
    White, H
    Simes, R
    Kirby, A
    Anderson, N
    Hankey, G
    Tonkin, A
    [J]. JOURNAL OF HYPERTENSION, 2000, 18 : S17 - S17
12345